This Clinical Statement was developed by TB and Ophthalmic specialists to improve and standardise patient care and support those managing patients with this disease, whether confirmed or suspected. The Clinical Statement outlines the current understanding of disease pathogenesis, diagnosis and management in adults, and also provides consensus points with the currently available data and best practices that can be applied in clinics.
Date: Tuesday 3 February 2026, 7pm to 8pmSpeaker: Lizzie GrilloPatient Representative: TBC This...
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...